These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16809486)

  • 1. Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus.
    Palma BD; Gabriel A; Colugnati FA; Tufik S
    Am J Physiol Regul Integr Comp Physiol; 2006 Nov; 291(5):R1527-32. PubMed ID: 16809486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased disease activity is associated with altered sleep architecture in an experimental model of systemic lupus erythematosus.
    Palma BD; Tufik S
    Sleep; 2010 Sep; 33(9):1244-8. PubMed ID: 20857872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sleep deprivation on the corticosterone secretion in an experimental model of autoimmune disease.
    Palma BD; Suchecki D; Catallani B; Tufik S
    Neuroimmunomodulation; 2007; 14(2):72-7. PubMed ID: 17713353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on prolactin secretion and binding to dopaminergic receptors in sleep-deprived lupus-prone mice.
    Palma BD; Hipolide DC; Tufik S
    Braz J Med Biol Res; 2009 Mar; 42(3):299-304. PubMed ID: 19287910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.
    Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR
    J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.
    Mendlovic S; Brocke S; Shoenfeld Y; Ben-Bassat M; Meshorer A; Bakimer R; Mozes E
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2260-4. PubMed ID: 3258423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval.
    Giles BM; Tchepeleva SN; Kachinski JJ; Ruff K; Croker BP; Morel L; Boackle SA
    J Immunol; 2007 Apr; 178(7):4667-75. PubMed ID: 17372026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated deaths from systemic lupus erythematosus in NZB x NZW F1 mice treated with the testosterone-blocking drug flutamide.
    Walker SE; Besch-Williford CL; Keisler DH
    J Lab Clin Med; 1994 Sep; 124(3):401-7. PubMed ID: 8083583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the pathogenesis of systemic lupus erythematosus.
    Jacob L; Viard JP; Louvard D; Bach JF
    Adv Nephrol Necker Hosp; 1990; 19():237-55. PubMed ID: 2105581
    [No Abstract]   [Full Text] [Related]  

  • 15. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
    Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
    J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
    Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
    Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin treatment attenuates proteinuria and prevents weight loss in NZB/W F1 mice.
    Paran D; Bernheim J; Golan I; Caspi D; Bernheim J; Benchetrit S
    Lupus; 2006; 15(8):526-31. PubMed ID: 16942006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
    Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
    J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.